SUBSCRIBE
SUBSCRIBE

Postmarket research

Drug Development
Safe New Therapy For Genetic Heart Disease, Na Homolce Hospital Clinical Trial Suggests
December 30, 2008
 · 
1 min read
Drug Development
Anti-Fungal Drug Offers Great Benefits To Some With Severe Asthma, University of Manchester Study
December 29, 2008
 · 
1 min read
Drug Development
Pain Pills May Cut Risk Of Bowel Cancer, National Institute of Environmental Health Sciences Study
December 29, 2008
 · 
1 min read
Drug Development
Gene Ups Risk for Those on Blood-Thinner Plavix, Hopital Pitie-Salpetriere Study
December 23, 2008
 · 
1 min read
Drug Development
Prozac Not Just for Depression Anymore, Tel Aviv University Study
December 19, 2008
 · 
1 min read
Drug Development
Common Treatment for Chronic Prostatitis Fails to Reduce Symptoms, Queen’s University Study
December 19, 2008
 · 
3 min read
Drug Development
Multiple Doses of Steroids Don’t Help Preemies, University of Toronto And Mount Sinai Hospital Study
December 19, 2008
 · 
1 min read
Drug Development
Phosphorus-Lowering Drugs Linked To Lower Mortality In Dialysis Patients, University of Miami Study
December 18, 2008
 · 
1 min read
Drug Development
Older Drugs Better at Fighting Depression in Parkinson’s Patients, Robert Wood Johnson Medical School Study
December 18, 2008
 · 
1 min read
Drug Development
Alzheimer’s Drugs Also Treat Behavioral, Psych Problems, Indiana University School of Medicine Study
December 18, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
FDA Grants Fast Track Designation For IntelliPharmaCeutics Rexista Oxycodone XR Incorporating PODRAS Technology
May 26, 2015
 · 
9 min read
Drug Development
Astellas Pharma US Release: Mirabegron As Add-On Treatment To Solifenacin Therapy Demonstrated Superior Results To Solifenacin Monotherapy In BESIDE Trial
May 18, 2015
 · 
8 min read
Drug Development
AbbVie Receives Orphan Drug Designation For HUMIRA (Adalimumab) From The FDA For The Investigational Treatment Of Moderate-To-Severe Hidradenitis Suppurativa (HS)
May 15, 2015
 · 
7 min read
Drug Development
Boehringer Ingelheim Release: First Patient Enrolled In Dabigatran Study Comparing Anticoagulation Strategies During AF Ablation
May 13, 2015
 · 
2 min read
Drug Development
Orexigen Provides Statement On Termination Of The Light Study And Updates On Contrave Collaboration With Takeda Pharmaceuticals
May 13, 2015
 · 
18 min read
Drug Development
Orexigen Aborts Required Study For Diet Drug Contrave
May 12, 2015
 · 
16 min read
Drug Development
Hemispherx Biopharma Europe N.V./S.A. Receives Orphan Medicine Designation By The Hemispherx Biopharma For Ampligen To Treat Patients With Ebola Virus Disease (EVD)
May 11, 2015
 · 
7 min read
Drug Development
Bristol-Myers Squibb Release: Long-Term, 7-Year Study Of Nulojix (Belatacept) Regimen Demonstrates Statistically Significant Relative Risk Reduction Of Death Or Graft Loss Over Cyclosporine Regimen In Kidney Transplant
May 6, 2015
 · 
13 min read
Drug Development
Kowa Pharmaceuticals America Release: New Meta-Analysis On Pitavastatin Demonstrates No Adverse Effect Compared With Placebo Or Other Statins On New-Onset Diabetes In Non-Diabetic Patients At Risk For Cardiovascular Disease
May 4, 2015
 · 
6 min read
Drug Development
Bayer HealthCare Release: Five-Year Follow-Up Study Further Supports Effectiveness And Safety Of The Essure Procedure As A Non-Surgical, Non-Hormonal Option For Permanent Contraception
May 1, 2015
 · 
7 min read
Drug Development
Actavis And Medicines360 Announce Publication Of ACCESS IUS Efficacy And Safety Study Of LILETTA (Levonorgestrel-Releasing Intrauterine System) 52 mg in Contraception
April 29, 2015
 · 
10 min read
Drug Development
Effect Of Genzyme’s Multiple Sclerosis Treatment Lemtrada (Alemtuzumab) On Slowing Brain Atrophy And MRI Lesion Activity Maintained Through Four Years
April 23, 2015
 · 
10 min read
Drug Development
Teva Presents Data Comparing Early Treatment With COPAXONE 40 Mg/Ml To Delayed Start Treatment At 67th American Academy of Neurology Annual Meeting In Washington, D.C.
April 23, 2015
 · 
8 min read
Drug Development
Biogen Release: TECFIDERA (Dimethyl Fumarate) Data Reinforce Strong, Sustained Efficacy For Newly-Diagnosed MS Patients
April 20, 2015
 · 
9 min read
Drug Development
Momenta Pharmaceuticals, Inc. Presents Key Glatopa (Glatiramer Acetate Injection) Data At American Academy of Neurology Annual Meeting
April 20, 2015
 · 
4 min read
Drug Development
Hemispherx Biopharma Europe N.V./S.A. Receives Positive Opinion On Application For Orphan Designation By The European Medicines Agency Agency For Ampligen To Treat Patients With Ebola Virus Disease (EVD)
March 24, 2015
 · 
8 min read
Drug Development
Hemispherx Biopharma To Present Data On The Activity Of Ampligen(R) Against The Ebola Virus
March 23, 2015
 · 
9 min read
Drug Development
Merz Aesthetics (Formerly Known as BioForm Medical, Inc.) Announces Primary Endpoint Met In Post-Market Clinical Study Of Xeomin (Incobotulinumtoxina) Vs. Botox® (Onabotulinumtoxina) For Glabellar Facial Lines
March 19, 2015
 · 
10 min read
Drug Development
Lundbeck Inc. Initiates Clinical Trial Evaluating Clobazam For Dravet Syndrome
March 17, 2015
 · 
4 min read
Drug Development
Boehringer Ingelheim Release: Many Atrial Fibrillation Patients At High Risk Of Stroke Fail To Receive Guideline-Recommended Oral Anticoagulant Treatment
March 16, 2015
 · 
4 min read
Load More